This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Pennsylvania. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Innovations in Metabolic Disease Treatment: The Contributions of Matthew Wilson
Introduction
Matthew Wilson, an innovative inventor based in Philadelphia, PA, has made significant strides in the biomedical field with his groundbreaking patents aimed at treating metabolic diseases. With a focus on enhancing the health of companion animals and advancing therapeutic strategies for humans, he exemplifies the spirit of modern-day inventors.
Latest Patents
Wilson holds two notable patents that illustrate his commitment to improving health outcomes. The first patent, titled "GLP-1 and use thereof in compositions for treating metabolic diseases," details compositions and methods specifically for treating type II diabetes. This invention features a unique viral vector designed to express a specific propeptide along with the active component of GLP-1, specifically tailoring it for subjects such as cats and dogs.
His second patent, "AAV-EPO for treating companion animals," provides a novel approach to treating erythropoietin deficiencies in companion animals through an adeno-associated viral vector. This invention also emphasizes the relevance of Wilson's work to both cats and dogs, enhancing veterinary medicine.
Career Highlights
Matthew Wilson is affiliated with the University of Pennsylvania, where he contributes to pioneering research and development in the fields of biotechnology and veterinary medicine. His career is marked by a keen focus on creating impactful solutions for both human and animal health challenges.
Collaborations
Throughout his career, Wilson has collaborated with leading experts in the field, including notable coworkers like Christian Hinderer and James M Wilson. These partnerships have facilitated the exchange of ideas and resources, enhancing the scope and depth of his research.
Conclusion
Matthew Wilson's work is a testament to innovation in treating metabolic diseases and contributing positively to animal health. His patents not only reflect his inventive spirit but also highlight the potential advancements in veterinary therapeutics. As the landscape of biomedical research continues to evolve, Wilson's contributions will undoubtedly play a crucial role in shaping the future of health treatments for both humans and their companion animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile